These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31427219)

  • 1. The CGM grey market: a reflection of global access inequity.
    Onisie O; Crocket H; de Bock M
    Lancet Diabetes Endocrinol; 2019 Nov; 7(11):823-825. PubMed ID: 31427219
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
    Perera R; Oliver N; Wilmot E; Marriott C
    Diabet Med; 2018 Nov; 35(11):1617-1618. PubMed ID: 29931731
    [No Abstract]   [Full Text] [Related]  

  • 3. Breakthroughs for Whom? Global Diabetes Care and Equitable Design.
    Moran-Thomas A
    N Engl J Med; 2016 Dec; 375(24):2317-2319. PubMed ID: 27974035
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing costs of type 1 diabetes care among US children and adolescents.
    Crossen S; Xing G; Hoch JS
    Pediatr Diabetes; 2020 Jun; 21(4):644-648. PubMed ID: 32061049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Technological Revolution: Winners and Losers?
    Barnard KD; Breton MD
    J Diabetes Sci Technol; 2018 Nov; 12(6):1227-1230. PubMed ID: 30035611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring: long live the revolution!
    Waldron-Lynch F; Herold KC
    Nat Clin Pract Endocrinol Metab; 2009 Feb; 5(2):82-3. PubMed ID: 19092785
    [No Abstract]   [Full Text] [Related]  

  • 7. Reimbursement and coverage implications for CGM.
    Aubry W
    Diabetes Technol Ther; 2005 Oct; 7(5):797-800. PubMed ID: 16241886
    [No Abstract]   [Full Text] [Related]  

  • 8. Best friend or spy: a qualitative meta-synthesis on the impact of continuous glucose monitoring on life with Type 1 diabetes.
    Messer LH; Johnson R; Driscoll KA; Jones J
    Diabet Med; 2018 Apr; 35(4):409-418. PubMed ID: 29247556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood glucose meters and test strips: global market and challenges to access in low-resource settings.
    Klatman EL; Jenkins AJ; Ahmedani MY; Ogle GD
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):150-160. PubMed ID: 30072234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring in the management of diabetes mellitus.
    McGahan L
    Issues Emerg Health Technol; 2002 May; (32):1-4. PubMed ID: 12096755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Current Intermittent-Scanning CGM Device Situation in Japan: Only Adjunctive Use to SMBG Is Approved and the Latest Health Insurance Coverage Details.
    Murata T; Sakane N; Kato K; Tone A; Toyoda M
    J Diabetes Sci Technol; 2018 May; 12(3):729-730. PubMed ID: 29281891
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges.
    Wood A; O'Neal D; Furler J; Ekinci EI
    Intern Med J; 2018 May; 48(5):499-508. PubMed ID: 29464891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of self-monitoring of blood glucose is an important factor limiting glycemic control in diabetic patients.
    Nyomba BL; Berard L; Murphy LJ
    Diabetes Care; 2002 Jul; 25(7):1244-5. PubMed ID: 12087028
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective.
    Sumnik Z; Szypowska A; Iotova V; Bratina N; Cherubini V; Forsander G; Jali S; Raposo JF; Stipančic G; Vazeou A; Veeze H; Lange K;
    Pediatr Diabetes; 2019 Jun; 20(4):434-443. PubMed ID: 30773756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring.
    Heinemann L; Freckmann G
    J Diabetes Sci Technol; 2015 Sep; 9(5):947-50. PubMed ID: 26330484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reimbursement for Continuous Glucose Monitoring.
    Heinemann L; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S248-52. PubMed ID: 26784130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Start-ups Tout Continuous Glucose Monitoring for People Without Diabetes.
    Jaklevic MC
    JAMA; 2021 Jun; 325(21):2140-2142. PubMed ID: 33978710
    [No Abstract]   [Full Text] [Related]  

  • 18. Reimbursement for continuous glucose monitoring: a European view.
    Heinemann L; Franc S; Phillip M; Battelino T; Ampudia-Blasco FJ; Bolinder J; Diem P; Pickup J; Hans Devries J
    J Diabetes Sci Technol; 2012 Nov; 6(6):1498-502. PubMed ID: 23294797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
    Hellmund R; Weitgasser R; Blissett D
    Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rosetta stone for insulin treatment: self-monitoring of blood glucose.
    Winter WE
    Clin Chem; 2004 Jun; 50(6):985-7. PubMed ID: 15161718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.